2 April 2024 - Breast cancer experts have urged PHARMAC to fast-track the drug Keytruda, for Kiwis with an aggressive form of breast cancer.
The drug is used to treat triple-negative breast cancer, and has been recommended by PHARMAC's cancer advisors to be funded for people with both early and advanced forms of the cancer.